CLEAR Harmony 1002-040 (Completed)
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER LONG-TERM SAFETY AND TOLERABILITY STUDY OF ETC-1002 IN PATIENTS WITH HYPERLIPIDEMIA AT HIGH CARDIOVASCULAR RISK WHO ARE NOT ADEQUATELY CONTROLLED BY THEIR LIPID-MODIFYING THERAPY
- Medicine
- ETC-1002
- Population
- Primairy prevention cardiovasular disease
- Phase
- III
- Starting year
- 2015
- More information
- ClinicalTrials.gov